A Real-world Study of Disease-modifying Therapy Treatment Outcomes in Patients With Spinal Muscular Atrophy

Clinical trial NCT07403214 · COMPLETED

Trial details

NCT number: NCT07403214
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Muscular Atrophy, Spinal

Start date: 2025-06-04
Primary completion: 2025-06-30
Enrollment: 4805

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.